The Western generics industry, from the United States to Israel, has in fact hardly been free of corruption. In May 2019 the attorneys general in forty-four American states filed suit against more than a dozen leading companies for colluding to fix prices at high levels for hundreds of products. 5 Among the defendants was Mylan Laboratories, which had achieved notoriety in 2016 for having precipitously hiked the price of its Epi-Pens, on which it held a market lock, by 400 percent. Headquartered in Morgantown, West Virginia, the company was led by Heather Bresch, the daughter of one of the state's senators, Joe Manchin. In 2018, already subject to a warning letter from the FDA for the operations of its flagship Indian plant, Mylan received another warning after FDA inspectors, responding to whistleblowers, discovered violations at its Morgantown plant.